Author

Subhamita Maitra

Mahidol UniversityORCID 0000-0003-4844-2660Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Bruno VincentiD· 1 shared Eirini AntoniouiD· 1 shared Henrik LindehelliD· 1 shared Ilknur Safak Demirel· 1 shared Iria Laura MartineziD· 1 shared Jakob J. E. StenmaniD· 1 shared Jiacheng ZhuiD· 1 shared Johan HolmbergiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Bruno VincentORCID

Author profile →

2 papers

Recent·Most cited

Cancer BiologyProceedings of the National Academy of SciencesPeer-reviewedOct 21, 2025

HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma.

Juan Yuan, Subhamita Maitra, Eirini Antoniou…·Johan Holmberg

This paper shows that HIF2α reduces MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma, suggesting HIF2 has tumor suppressor rather than oncogenic function.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintMay 26, 2022

ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic system

Subhamita Maitra, Bruno Vincent

This study shows that ADAM10 inhibition reduces dopamine receptor D4 levels and increases dopamine-degrading enzyme expression in neuroblastoma cells, suggesting a potential role in Alzheimer's disease psychosis.

DOI 10.1101/2022.05.26.493662

humanproteomics

𝕏 PostBluesky